NFG
VIR icon

Next Financial Group’s Vir Biotechnology VIR Stock Holding History

Next Financial Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$5K Sell
129
-71
-36% -$2.78K ﹤0.01% 2441
2021
Q3 		$9K Hold
200
– – ﹤0.01% 2077
2021
Q2 		$9K Hold
200
– – ﹤0.01% 2036
2021
Q1 		$10K Buy
+200
New +$10.8K ﹤0.01% 1894

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return

Next Financial Group's VIR Position: Q4 2021 in Review

Next Financial Group reduced its Vir Biotechnology (VIR) stake by 36% in Q4 2021, selling an estimated $2.78K and leaving 129 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #2441.

Next Financial Group first reported a position in VIR in Q1 2021 and has held it in 4 quarters since. The position peaked at $10K in Q1 2021. 210 funds tracked by Wall St. Rank hold VIR as of Q4 2021.

  • Next Financial Group held 129 shares of Vir Biotechnology worth $5K as of Q4 2021.
  • Next Financial Group sold 71 Vir Biotechnology shares in Q4 2021, an estimated $2.78K.
  • Vir Biotechnology made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2441 holding.
  • Next Financial Group first reported a position in Vir Biotechnology in Q1 2021 and has held it in 4 quarters since.
  • Next Financial Group's Vir Biotechnology position peaked at $10K in Q1 2021.
  • 210 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.